Search
for
Sort by
Research 691–720 of 1000+
- Common Causes of Hair Loss and Their Treatment Options
- Prolactin: an emerging force along the cutaneous–endocrine axis
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
- Nanotechnological reprogramming of the pathological skin microenvironment in scar formation and atopic dermatitis
- Therapeutic Approach to Vaccine-Induced Ischemic Dermatopathy in a Pomeranian Dog with Refractory Alopecia
- Evidence-Based Homeopathy: A case study on alopecia areata in a 6-year-old child
- Mechanistic study of Erianin in alopecia areata
- Alopecia areata, actualización clínica y terapéutica
- Poster Abstracts
- British Society for Dermatopathology
- 174 Changes in urine androgen and PG levels during finasteride treatment
- Recent Formulation Advances of Mangiferin
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- Radiotherapy-Induced Skin Fibrosis: Pathophysiology, Emerging Therapeutics, and the Role of Dermatology
- Geriatric Dermatologic Therapy
- A prospective, interventional, randomized, open-label, comparative, three-arm, parallel allocation, single-center clinical study to evaluate the effectiveness of Venusia CeraPlus cream and lotion as an adjuvant in the treatment of atopic dermatitis
- Comparative safety profiles of baricitinib and tofacitinib in the treatment of adult alopecia areata: a pharmacovigilance study based on the FAERS database
- Korean Consensus Criteria for the Severity Classification of Alopecia Areata
- Increase in IL-15 levels in patients with alopecia areata
- Review of the Use of Platelet-Rich Plasma in the Treatment of Alopecia
- Lipid nanocarriers as innovative strategies for hair regrowth
- Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need!
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- Artificial Intelligence in Hair Disorders: A Narrative Review
- Real-world pharmacovigilance insights into drug-induced risk of alopecia
- Consider Cultural Practices and Barriers to Care When Treating Alopecia Areata
- Risk factors for the development of and outcomes after diagnosis of autoimmune alopecia areata in patients with inflammatory bowel diseases
- Central Centrifugal Cicatricial Alopecia (CCCA): Unraveling the Complexities of a Scarring Hair Disorder
- 448 Challenges of securing insurance approval for oral tofacitinib treatment of alopecia areata: A multi-institutional retrospective review
- Female hair loss